Back to results
US 8,772,296 B2Granted
Benzamide derivatives and uses related thereto
AssigneeAmgen Inc.
InventorsJay P. Powers, Michael Degraffenreid, Lisa Julian, Jacob Kaizerman, Dustin McMinn, Yosup Rew, Daqing Sun, Xuelei Yan, Zhulun Wang, Felix Gonzalez Lopez De Turiso
Life of this patent
Estimating the term…
Abstract
Benzamide derivatives of formula I are described and have therapeutic utility, particularly in the treatment of diabetes, obesity and related conditions and disorders: wherein R1, R2, R3, R4, R5, R6, R7, R8, and n are as defined herein.
Claims23
A compound having the formula (I):
- or pharmaceutically acceptable salts, solvates, stereoisomers or prodrugs thereof,
- wherein:
- n is 0;
- R1 is a member selected from the group consisting of —OH, halogen and (C1-C8)haloalkyl;
- R2 and R3 are members independently selected from the group consisting of halogen, (C1-C8)alkyl, (C2-C8)alkenyl, (C2-C8)alkynyl, (C1-C8)alkoxy, (C1-C8)haloalkyl, (C2-C8)hydroxyalkyl and (C3-C8)cycloalkyl, wherein no more than two of R1, R2 and R3 are halogen;
- R4 is a member selected from the group consisting of hydrogen, halogen, (C1-C8)alkyl and (C3-C8)cycloalkyl;
- R5 is selected from the group consisting of (C1-C8)alkyl, (C1-C8)haloalkyl, (C2-C8)hydroxyalkyl, (C3-C8)cycloalkyl, and (C3-C8)heterocycloalkyl;
- R6 is selected from the group consisting of (C2-C8)alkenyl, (C1-C8)haloalkyl, aryl(C1-C6)alkyl, (C3-C8)cycloalkyl, (C3-C8)heterocycloalkyl, heteroaryl, and aryl;
- wherein each aryl and heteroaryl group is optionally substituted by substituents numbering from one to the number of open valences on the aryl or heteroaryl group selected from the group consisting of -halo, —OR′, —OC(O)R′, —NR′R″, —SR′, —R′, —CN, —NO2, —CO2R′, —C(O)NR′R″, —C(O)R′, —OC(O)NR′R″, —NR″C(O)R′, —NR″CO2R′, —NR′″C(O)NR′R″, —NR′″SO2NR′R″, —NHC(NH2)═NH, —NR′C(NH2)═NH, —NH—C(NH2)═NR′, —S(O)R′, —SO2R′, —SO2NR′R″, —NR″SO2R′, —N3, —CH(Ph)2, perfluoroalkoxy and perfluoro(C1-C4)alkyl;
- wherein R5 or R6 is optionally substituted with from one to two members selected from the group consisting of halogen, —CN, —NO2, (C1-C4)alkyl, (C2-C8)alkenyl, (C2-C8)alkynyl, (C1-C4)alkoxy, (C1-C4)haloalkyl, (C2-C4)hydroxyalkyl, —C(O)R′, —C(O)OR′, —NR′C(O)OR′, —OR′, —SR′, —OC(O)R′, —C(O)N(R′)2, —S(O)R′, —SO2R′, —SO2N(R′)2, —N(R′)2, —NR′C(O)R′ and —NR′ SO2R′;
- R7 is selected from the group consisting of —CN, (C2-C8)alkyl, (C2-C8)alkenyl, (C2-C8)alkynyl, (C1-C8)haloalkyl, (C1-C8)hydroxyalkyl, —C(O)R′, —C(O)OR′, —NR′C(O)OR′, —OR′, —OC(O)R′, —C(O)N(R′)2, —S(O)R′, —SO2R′, —SO2N(R′)2, —N(R′)2, —NR′C(O)R′, —NR′SO2R′, —X—CN, —X—C(O)R′, —X—C(O)OR′, —X—NR′C(O)OR′, —X—OR′, —X—OC(O)R′, —X—C(O)N(R′)2, —X—S(O)R′, —X—SO2R′, —X—SO2N(R′)2, —X—N(R′)2, —X—NR′C(O)R′,
- wherein each alkyl, alkenyl, and alkynyl can be substituted by one to three substitutents selected from the group consisting of —OR′, ═O, ═NR′, ═N—OR′, —NR′R″, —SR′, -halo, —SiR′R″R′″, —OC (O)R′, —C(O)R′, —CO2R′, —CONR′R″, —OC(O)NR′R″, —NR″C(O)R′, —NR′″C(O)NR′R″, —NR′″SO2NR′R″, —NR″CO2R′, —NHC(NH2)═NH, —NR′C(NH2)═NH, —NHC(NH2)═NR′, —S(O)R′, —SO2R′, —SO2NR′R″, —NR″SO2R′, —CN and —NO2;
- R6 and R7 may be combined to form a (C3-C8)cycloalkyl or (C3-C8)heterocycloalkyl;
- R8 is selected from the group consisting of halogen, —CN, (C1-C6)alkyl, (C1-C6)alkyloxy, and —OH;
- X is a branched or straight chain (C1-C8)alkylene group;
- each occurrence of R′, R″, and R′″ is independently hydrogen or an unsubstituted member selected from the group consisting of (C1-C8)alkyl, (C2-C8)alkenyl, (C2-C8)alkynyl, (C1-C4)alkoxy(C1-C4)alkyl, (C1-C8)haloalkyl, (C2-C8)hydroxyalkyl, (C3-C8)cycloalkyl, (C3-C8)heterocycloalkyl, heteroaryl, aryl, (C3-C8)cycloalkyl(C1-C6)alkyl, (C3-C8)heterocycloalkyl(C1-C6)alkyl, heteroaryl(C1-C6)alkyl, aryl(C1-C6)alkyl, or two R′ groups, when attached to the same nitrogen atom, can be combined with the nitrogen atom to which they are attached to form a heterocycle or heteroaryl group;
- and
- with the proviso that when R1 is —OH, then R2 and R3 are not both CF3.
15 more elements
A compound selected from the group consisting of:
- or a pharmaceutically acceptable salt, solvate, stereoisomer or prodrug thereof.
Dependencies are inferred from the claim text.